AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Darbitop Injection

Prescription Icon
Prescription Required

Marketer

Alniche Life Sciences Pvt Ltd

Salt Composition

Darbepoetin alfa (60mcg)

Overview Darbitop Injection

Darbitop Injection treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation to increase red blood cell production. Administered under medical supervision, Darbitop requires cautious use due to potential serious adverse reactions. Expert medical guidance is essential; patients must strictly adhere to their doctor's instructions. Common side effects encompass abdominal discomfort, hypertension, rash, injection site pain, dyspnea, cough, and peripheral edema. Report symptoms of severe hypertension—intense headache, visual disturbances, nausea, vomiting, or seizures—immediately. Regular blood tests monitoring electrolytes (like potassium), hemoglobin, and blood cell counts are typically performed. Discontinue use and seek medical advice if shortness of breath or a skin rash develops. Prior to treatment, disclose any history of heart disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, or intending to become pregnant or breastfeed individuals must consult their physician regarding safety.

Primary Ingredients of Darbitop Injection

No information provided. Please provide the text you wish to be rephrased.

Uses of Darbitop Injection

Managing Anemia in Chronic Kidney Disease and Cancer Chemotherapy

Major Benefits of Darbitop Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Darbitop Injection:

  • Abdominal pain
  • High blood pressure
  • Rash
  • Injection site pain
  • Breathlessness
  • Cough
  • Peripheral edema
  • Procedural hypotension (low blood pressure)
  • Convulsion
  • Thromboembolism

How to use Darbitop Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Darbitop Injection works:

Darbitop Injection is a medication that boosts red blood cell production. This erythropoiesis-stimulating agent (ESA) acts by prompting the bone marrow — the blood cell-producing tissue within bones — to increase red blood cell synthesis.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Darbitop Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Darbitop Injection's use during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Darbitop Injection while breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Darbitop Injection.

KidneyKidneySAFE IF PRESCRIBED

Darbitop Injection poses no safety concerns for patients with renal impairment; no dosage modification is necessary.

LiverLiverCAUTION

For individuals with hepatic impairment, Darbitop Injection requires careful administration. Dosage modifications for Darbitop Injection may be necessary. Physician consultation is advised.

What if you forget to take Darbitop Injection :

Should you forget a Darbitop Injection dose, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Darbitop Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP
Actions Erythropoietin-stimulating drug

FAQs on Darbitop Injection

Expect a rise in your red blood cell count (hemoglobin) within 2 to 6 weeks of beginning Darbitop injections. Consult your doctor with any questions.
Darbitop Injection carries a risk of serious side effects, including potentially fatal consequences, and requires careful administration. Expert medical supervision by a physician experienced with Darbitop Injection therapy is essential. Adhere strictly to all prescribed instructions.
Darbitop Injection may be ineffective if you have iron, folic acid, or vitamin B12 deficiencies; these should be addressed before treatment. Other factors that can hinder response include bleeding, infections, inflammation, and bone marrow fibrosis. Consult your doctor for further guidance.
Darbitop Injection treats anemia related to chronic kidney disease in children over one year old. Its effectiveness and side effects are comparable to those seen in adults. Consult your doctor for any concerns.
Darbitop Injection can alter blood pressure. Monitor blood pressure closely, especially at the start of treatment. Patients with hypertension should manage their blood pressure appropriately. Discontinuation of Darbitop Injection may be necessary if blood pressure remains uncontrolled.
Darbitop Injection should only be used under a doctor's prescription. It is contraindicated for individuals with uncontrolled hypertension, a history of pure red cell aplasia (PRCA) triggered by Darbitop or similar erythropoietin medications, or a history of serious allergic reactions to this drug.
Darbitop Injection
3,888
MRP 4,500
13% off